Range
1.23 - 1.3
Vol / Avg.
1.4M/8.4M
Div / Yield
-
52 Wk
1.22 - 2.36
Mkt Cap
414.1M
Payout Ratio
-
Open
1.25
P/E
-
EPS
-0.09
Shares
318.6M
Outstanding
318.6M
Total Float
316.4M
Sector: Health Care.Industry: Biotechnology
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.080-0.090 -0.0100
REV50.000K137.000K87.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GERNGeron0%414.1M

Geron Frequently Asked Questions

Q

How do I buy Geron (GERN) stock?

A

You can purchase shares of Geron (NASDAQ: GERN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Geron (GERN) stock?

A

The latest price target for Geron (NASDAQ: GERN) was reported by HC Wainwright & Co. on August 26, 2020. The analyst firm set a price target for 7.00 expecting GERN to rise to within 12 months (a possible 438.46% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Geron (GERN)?

A

The stock price for Geron (NASDAQ: GERN) is $1.3 last updated Today at 8:00:02 PM.

Q

Does Geron (GERN) pay a dividend?

A

There are no upcoming dividends for Geron.

Q

When is Geron (NASDAQ:GERN) reporting earnings?

A
Geron’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Geron (GERN) going to split?

A

There is no upcoming split for Geron.

Q

What sector and industry does Geron (GERN) operate in?

A

Geron is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.